Skip to main content

university-system-of-maryland-usm-2-logo

The National Institutes of Health has awarded a University System of Maryland institute a $6 million grant to develop a vaccine for the hepatitis C virus.

The Institute for Bioscience and Biotechnology Research will conduct the grant-funded research over a five-year period. The institute is a joint research enterprise between the University of Maryland, College Park, the University of Maryland, Baltimore and the National Institute of Standards and Technology.

{iframe}http://www.bizjournals.com/baltimore/news/2017/06/12/usm-institute-wins-6-million-grant-to-develop.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.